Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.130
-0.090 (-4.05%)
Jul 17, 2026, 4:10 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 416.54 million as of July 17, 2026. Its market cap has increased by 106.68% in one year.
Market Cap
416.54M
Enterprise Value
395.60M
Revenue
3.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.13
ChartMarket Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 416.54M, an increase of 3,196.16%. That is a compound annual growth rate of 41.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 416.54M | -15.62% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 914.05M |
| Clinuvel Pharmaceuticals | 509.83M |
| Tetratherix | 361.30M |
| Starpharma Holdings | 307.44M |
| Orthocell | 202.83M |
| Actinogen Medical | 149.98M |
| Dimerix | 144.10M |
| Alterity Therapeutics | 128.33M |